Skip to main navigation Skip to search Skip to main content

Muscle histology vs MRI in Duchenne muscular dystrophy

  • M. Kinali
  • , V. Arechavala-Gomeza
  • , S. Cirak
  • , A. Glover
  • , M. Guglieri
  • , L. Feng
  • , K. G. Hollingsworth
  • , D. Hunt
  • , H. Jungbluth
  • , H. P. Roper
  • , R. M. Quinlivan
  • , J. A. Gosalakkal
  • , S. Jayawant
  • , A. Nadeau
  • , L. Hughes-Carre
  • , A. Y. Manzur
  • , Eugenio Maria Mercuri
  • , J. E. Morgan
  • , V. Straub
  • , K. Bushby
  • C. Sewry, M. Rutherford, F. Muntoni
  • University College London
  • Hammersmith Hospital
  • Newcastle University
  • St. Mary's Hospital
  • Evelina London Children's Healthcare
  • University Hospitals Birmingham NHS Foundation Trust
  • University Hospitals of Leicester
  • John Radcliffe Hospital
  • Departments of Paediatrics

Research output: Contribution to journalArticle

Abstract

There are currently no effective treatments to halt the muscle breakdown in Duchenne muscular dystrophy (DMD), although genetic-based clinical trials are being piloted. Most of these trials have as an endpoint the restoration of dystrophin in muscle fibers, hence requiring sufficiently well-preserved muscle of recruited patients. The choice of the muscles to be studied and the role of noninvasive methods to assess muscle preservation therefore require further evaluation.
Original languageEnglish
Pages (from-to)346-353
Number of pages8
JournalNeurology
Volume76
DOIs
Publication statusPublished - 2011

Keywords

  • Adolescent
  • Child
  • Foot
  • Humans
  • Leg
  • Magnetic Resonance Imaging
  • Male
  • Muscle, Skeletal
  • Muscular Dystrophy, Duchenne

Fingerprint

Dive into the research topics of 'Muscle histology vs MRI in Duchenne muscular dystrophy'. Together they form a unique fingerprint.

Cite this